Form D · Pharmaceuticals
Promentis Pharmaceuticals, Inc.
Milwaukee, WI · CIK 0001470994
Offering snapshot reported Dec 27, 2019 · SEC filing
- Reported sold
- $2.5M Offering amount: $6M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 10, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 27, 2019 | Initial | $2,500,000 | No comparison | 8 | SEC filing |
| Sep 25, 2017 | Initial | $17,574,799 | No comparison | 8 | SEC filing |
| Oct 5, 2016 | Initial | $8,787,399 | No comparison | 8 | SEC filing |
| Jan 15, 2014 | Initial | $820,156 | No comparison | 6 | SEC filing |
| Apr 1, 2013 | Initial | $750,000 | No comparison | 6 | SEC filing |
| Aug 31, 2009 | Amendment | $1,687,000 | $0vs Aug 28, 2009 | 5 | SEC filing |
| Aug 28, 2009 | Initial | $1,687,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-356545
Source: Form D, filed Dec 27, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Baker, Ph D | Director |
| Ed Barthell | Director |
| Ed Barthell, Md | Director |
| Thomas Beck | Director |
| Tom Beck | Director, Executive |
| Chad Beyer | Executive |
| Chad E Beyer, Ph D | Director, Executive |
| Daniel Lawton | Director, Executive |
| Virinder Nohria, Ph D | Director |
| Patrick Schwarz Schuette | Director |
| Stacey Seltzer | Director |
| Thomas Shannon | Director |
| Steve Squinto | Director |
| Klaus Veitinger | Director |
| Klaus Veitinger, Md, Ph D | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
826 N. Plankinton Ave., Ste. 400
Milwaukee, WI, 53203
Milwaukee, WI, 53203